Press & Media Centre
Welcome to the Cannamedical Britannia press and media centre. Here you will find company information, key statistics, press releases, and contact details for media enquiries.
Company Overview
Cannamedical Britannia is the UK subsidiary of the Semdor Pharma Group, one of Europe’s leading pharmaceutical-grade medical cannabis companies. The company operates at the intersection of clinical medicine and pharmaceutical manufacturing, supplying EU-GMP certified cannabis-based medicines to prescribing specialists and licensed pharmacies across the United Kingdom.
Cannamedical Britannia is patient-focused, science-led, and quality-driven — committed to improving patient outcomes through the highest standards of medical cannabis supply and clinical support.
Key Statistics
- 120,000+ patients receiving medical cannabis through the Semdor Pharma Group network
- 1,100+ dispensing pharmacies supplied across Europe
- 30+ EU-GMP certified cultivators and manufacturers in the supply network
- 100+ certified medical cannabis products in the formulary
- Founded in Germany, with operations spanning Europe and now expanding into the UK market
About the Semdor Pharma Group
Semdor Pharma Group is a pharmaceutical company specialising in cannabis-based medicines, with subsidiaries and distribution partnerships across Germany, the Netherlands, Portugal, and other European markets. The group operates under strict pharmaceutical regulatory frameworks and is committed to expanding patient access to safe, effective, and consistently manufactured medical cannabis.
The establishment of Cannamedical Britannia marks the group’s entry into the United Kingdom — a market of significant clinical and commercial opportunity as awareness and acceptance of cannabis-based medicines continues to grow among UK prescribers and patients.
Media Assets
High-resolution logos, brand guidelines, and approved product photography are available for accredited media upon request. Please contact our press team to receive a media pack.
Press Releases
Our latest press releases and announcements are published on the Cannamedical Britannia Blog. For archive requests or background briefings, please contact the press team directly.
Media Contact
For all press and media enquiries, including interview requests, product information, and background briefings:
Email: press@cannamedical.com
Response time: We aim to respond to all media enquiries within one business day.
Company Boilerplate
About Cannamedical Britannia: Cannamedical Britannia is the UK operating entity of the Semdor Pharma Group, a leading European pharmaceutical-grade medical cannabis company. We supply EU-GMP certified cannabis-based medicines to specialist prescribers and licensed pharmacies across the United Kingdom, supporting patients with chronic conditions where conventional treatments have proved insufficient. Cannamedical Britannia is registered in England and Wales. For more information, visit cannamedical.co.uk.
Social Media
Follow Cannamedical Britannia for clinical updates, patient stories, and industry news.